Robert Sehlke
@rogepese.bsky.social
co-founder @ graphtx.com
Systems biology, more translatable disease models, & ML. Still confused, but with a higher significance.
Systems biology, more translatable disease models, & ML. Still confused, but with a higher significance.
Reposted by Robert Sehlke
We're hiring! 📢
Our team is looking for a Quantitative Systems Biologist driving research at the interface of computational and lab biology. 🧪🥼🔍
Want to know more? Reach out to us and apply via the link below! ⬇️
www.linkedin.com/jobs/view/42...
Our team is looking for a Quantitative Systems Biologist driving research at the interface of computational and lab biology. 🧪🥼🔍
Want to know more? Reach out to us and apply via the link below! ⬇️
www.linkedin.com/jobs/view/42...
Graph Therapeutics hiring Quantitative Systems Biologist (m/f/d) in Klosterneuburg, Lower Austria, Austria | LinkedIn
Posted 4:35:54 PM. Be at the forefront of AI-driven precision immunology for drug discoverytl;dr: Graph is an…See this and similar jobs on LinkedIn.
www.linkedin.com
June 14, 2025 at 7:45 AM
We're hiring! 📢
Our team is looking for a Quantitative Systems Biologist driving research at the interface of computational and lab biology. 🧪🥼🔍
Want to know more? Reach out to us and apply via the link below! ⬇️
www.linkedin.com/jobs/view/42...
Our team is looking for a Quantitative Systems Biologist driving research at the interface of computational and lab biology. 🧪🥼🔍
Want to know more? Reach out to us and apply via the link below! ⬇️
www.linkedin.com/jobs/view/42...
Reposted by Robert Sehlke
¡Hola! 🇪🇸 We’re looking forward to seeing everyone at the @irbbarcelona.org for the AI in Drug Discovery and Biomedicine conference. If you’re around, reach out to @izepb.bsky.social and let's meet up! 👋
March 24, 2025 at 10:10 AM
¡Hola! 🇪🇸 We’re looking forward to seeing everyone at the @irbbarcelona.org for the AI in Drug Discovery and Biomedicine conference. If you’re around, reach out to @izepb.bsky.social and let's meet up! 👋
Reposted by Robert Sehlke
We're back on the circuit at BIO-Europe Spring in Milan! ☕ 🇮🇹
@gregvladimer.bsky.social kicked off the 2nd day with a presentation about Graph, specifically how we combine complex immunological models, multi-modal data, and AI to tackle the drug discovery complexities of immune-mediated diseases. 👏
@gregvladimer.bsky.social kicked off the 2nd day with a presentation about Graph, specifically how we combine complex immunological models, multi-modal data, and AI to tackle the drug discovery complexities of immune-mediated diseases. 👏
March 18, 2025 at 2:35 PM
We're back on the circuit at BIO-Europe Spring in Milan! ☕ 🇮🇹
@gregvladimer.bsky.social kicked off the 2nd day with a presentation about Graph, specifically how we combine complex immunological models, multi-modal data, and AI to tackle the drug discovery complexities of immune-mediated diseases. 👏
@gregvladimer.bsky.social kicked off the 2nd day with a presentation about Graph, specifically how we combine complex immunological models, multi-modal data, and AI to tackle the drug discovery complexities of immune-mediated diseases. 👏
Reposted by Robert Sehlke
Graph Therapeutics announces the closing of a $3.1M pre-seed round aimed at bringing the precision medicine paradigm to inflammation and immunology (I&I). 🚀🔬🧬
Looking forward to great things to come!
Read more ➡️ graphtx.com/news#graph-p...
Looking forward to great things to come!
Read more ➡️ graphtx.com/news#graph-p...
January 10, 2025 at 8:32 PM
Graph Therapeutics announces the closing of a $3.1M pre-seed round aimed at bringing the precision medicine paradigm to inflammation and immunology (I&I). 🚀🔬🧬
Looking forward to great things to come!
Read more ➡️ graphtx.com/news#graph-p...
Looking forward to great things to come!
Read more ➡️ graphtx.com/news#graph-p...